{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:31:59Z","timestamp":1771047119814,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.intimp.2015.02.017","type":"journal-article","created":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T14:01:30Z","timestamp":1424354490000},"page":"416-424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Anticancer effects of adenovirus-mediated calreticulin and melanoma-associated antigen 3 expression on non-small cell lung cancer cells"],"prefix":"10.1016","volume":"25","author":[{"given":"Xinli","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jijia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianqiao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongkai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujuan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2015.02.017_bb0005","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.intimp.2015.02.017_bb0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc3775","article-title":"Non-small-cell lung cancers: a heterogeneous set of diseases","volume":"14","author":"Chen","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.intimp.2015.02.017_bb0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/1566523214666140612151726","article-title":"Dual receptor-specific peptides modified liposomes as VEGF siRNA vector for tumor-targeting therapy","volume":"14","author":"Yang","year":"2014","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.intimp.2015.02.017_bb0020","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0140-6736(13)61715-8","article-title":"Genetics and biomarkers in personalisation of lung cancer treatment","volume":"382","author":"Rosell","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2015.02.017_bb0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/1570163811310020010","article-title":"Treatment of lung cancer using nanoparticle drug delivery systems","volume":"10","author":"Chandolu","year":"2013","journal-title":"Curr Drug Discov Technol"},{"key":"10.1016\/j.intimp.2015.02.017_bb0030","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3748\/wjg.v10.i13.1849","article-title":"Biological functions of melanoma-associated antigens","volume":"10","author":"Xiao","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.intimp.2015.02.017_bb0035","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF01246677","article-title":"Structure, chromosomal localization, and expression of 12 genes of the MAGE family","volume":"40","author":"ADe Plaen","year":"1994","journal-title":"Immunogenetics"},{"key":"10.1016\/j.intimp.2015.02.017_bb0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S","article-title":"Tumor regressions observed in patients with metastatic treated with antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1","volume":"80","author":"Marchand","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.intimp.2015.02.017_bb0045","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1111\/j.1349-7006.2009.01303.x","article-title":"Cancer\/testis (CT) antigens: potential targets for immunotherapy","volume":"100","author":"Caballero","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.intimp.2015.02.017_bb0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejcts.2003.09.015","article-title":"Melanoma associated antigen (MAGE)-A3 expression in stages I and II non-small cell lung cancer: results of a multi-center study","volume":"25","author":"Sienel","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.intimp.2015.02.017_bb0055","first-page":"S97","article-title":"Cancer\/testis antigens for therapeutic use","volume":"14","author":"Mathieu","year":"2009","journal-title":"J Buon"},{"key":"10.1016\/j.intimp.2015.02.017_bb0060","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.1074\/jbc.273.11.6009","article-title":"Enhanced catalysis of ribonuclease B folding by the interaction of calnexin or calreticulin with ERp57","volume":"273","author":"Zapun","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2015.02.017_bb0065","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1091\/mbc.6.9.1173","article-title":"Transient, lectin-like association of calreticulin with folding intermediates of cellular and viral glycoproteins","volume":"6","author":"Peterson","year":"1995","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.intimp.2015.02.017_bb0070","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.biocel.2004.02.030","article-title":"Calreticulin, a Ca2+-binding chaperone of the endoplasmic reticulum","volume":"37","author":"Gelebart","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"issue":"15","key":"10.1016\/j.intimp.2015.02.017_bb0075","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1182\/blood-2014-01-550434","article-title":"CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis","volume":"123","author":"Rumi","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2015.02.017_bb0080","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.cgt.7700956","article-title":"Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity","volume":"13","author":"Cheng","year":"2006","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.intimp.2015.02.017_bb0085","doi-asserted-by":"crossref","first-page":"882","DOI":"10.2353\/ajpath.2009.080417","article-title":"Suppressive roles of calreticulin in prostate cancer growth and metastasis","volume":"175","author":"Alur","year":"2009","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.intimp.2015.02.017_bb0090","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/jcp.24519","article-title":"Overexpression of calreticulin contributes to the development and progression of pancreatic cancer","volume":"229","author":"Sheng","year":"2014","journal-title":"J Cell Physiol"},{"issue":"3","key":"10.1016\/j.intimp.2015.02.017_bb0095","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1021\/pr2005692","article-title":"Proteomic profile of human aortic stenosis: insights into the degenerative process","volume":"11","author":"Mart\u00edn-Rojas","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.intimp.2015.02.017_bb0100","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1158\/1078-0432.CCR-07-1930","article-title":"Suppression of lung tumor growth and metastasis in mice by adeno-associated virus-mediated expression of vasostatin","volume":"14","author":"Cai","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.intimp.2015.02.017_bb0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fonc.2014.00074","article-title":"Oncolytic immunotherapy: dying the right way is a key to eliciting potent antitumor immunity","volume":"4","author":"Guo","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.intimp.2015.02.017_bb0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-9966-31-8","article-title":"Adenovirus-mediated delivery of CALR and MAGE-A3 inhibits invasion and angiogenesis of glioblastoma cell line U87","volume":"31","author":"Liu","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.intimp.2015.02.017_bb0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.intimp.2015.02.017_bb0120","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2015.02.017_bb0125","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ijc.21183","article-title":"International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising","volume":"117","author":"Devesa","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.intimp.2015.02.017_bb0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/JTO.0b013e3181c5920c","article-title":"Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey","volume":"5","author":"Morgensztern","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.intimp.2015.02.017_bb0135","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1200\/JCO.2010.30.7074","article-title":"Strategies for prolonged therapy in patients with advanced non-small-cell lung cancer","volume":"28","author":"Fidias","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.intimp.2015.02.017_bb0140","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1158\/1535-7163.MCT-13-0699","article-title":"Preclinical evaluation of the supercritical extract of Azadirachta indica (neem) leaves in vitro and in vivo on inhibition of prostate cancer tumor growth","volume":"13","author":"Wu","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"10.1016\/j.intimp.2015.02.017_bb0145","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.ctrv.2014.06.006","article-title":"Targeting the phosphatidylinositol 3-kinase (PI3K)\/AKT\/mammalian target of rapamycin (mTOR) pathway: an emerging treatment strategy for squamous cell lung carcinoma","volume":"40","author":"Beck","year":"2014","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"10.1016\/j.intimp.2015.02.017_bb0150","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.pharmthera.2013.12.004","article-title":"Molecular targets for cancer therapy in the PI3K\/AKT\/mTOR pathway","volume":"142","author":"Polivka","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.intimp.2015.02.017_bb0155","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ctrv.2013.08.006","article-title":"Strategies for co-targeting the PI3K\/AKT\/mTOR pathway in NSCLC","volume":"40","author":"Heavey","year":"2014","journal-title":"Cancer Treat Rev"},{"issue":"24","key":"10.1016\/j.intimp.2015.02.017_bb0160","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1182\/blood-2014-03-530865","article-title":"From Janus kinase 2 to calreticulin: the clinically relevant genomic landscape of myeloproliferative neoplasms","volume":"123","author":"Cazzola","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2015.02.017_bb0165","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1242\/jcs.039131","article-title":"Transcriptional regulation of the cyclin D1 gene at a glance","volume":"121","author":"Klein","year":"2008","journal-title":"J Cell Sci"},{"key":"10.1016\/j.intimp.2015.02.017_bb0170","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/jcp.21791","article-title":"Nuclear cyclin D1: an oncogenic driver in human cancer","volume":"220","author":"Kim","year":"2009","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.intimp.2015.02.017_rf0195","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1084\/jem.189.5.797","article-title":"Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity","volume":"189","author":"Basu","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2015.02.017_rf0200","doi-asserted-by":"crossref","first-page":"8055","DOI":"10.1158\/1078-0432.CCR-05-1203","article-title":"Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer","volume":"11","author":"Gure","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.intimp.2015.02.017_bb0180","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ni.2366","article-title":"IL-12 family cytokines: immunological playmakers","volume":"13","author":"Vignali","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2015.02.017_bb0185","doi-asserted-by":"crossref","first-page":"9008","DOI":"10.1200\/JCO.2005.08.375","article-title":"Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells","volume":"23","author":"Van Baren","year":"2005","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.intimp.2015.02.017_bb0190","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1158\/1078-0432.CCR-14-0583","article-title":"Calreticulin promotes migration and invasion of esophageal cancer cells by upregulating neuropilin-1 expression via STAT5A","volume":"20","author":"Shi","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.intimp.2015.02.017_bb0195","doi-asserted-by":"crossref","first-page":"882","DOI":"10.2353\/ajpath.2009.080417","article-title":"Suppressive roles of calreticulin in prostate cancer growth and metastasis","volume":"175","author":"Alur","year":"2009","journal-title":"Am J Pathol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915000648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915000648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T02:49:13Z","timestamp":1566355753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576915000648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1567576915000648"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2015.02.017","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticancer effects of adenovirus-mediated calreticulin and melanoma-associated antigen 3 expression on non-small cell lung cancer cells","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2015.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}